Award
National Institute of Allergy and Infectious Diseases 5R44AI179371-03
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
Recipient
ABVACC, INC.
Award Amount
$1,000,000.00
Ceiling
$1,000,000.00
Awarded
May 19, 2026
Identifier
5R44AI179371-03
Award for developing a monoclonal antibody cocktail to treat Marburg virus disease, including production, testing, and manufacturing development, funded by NIH/NIAID.
Description
The project involves developing a monoclonal antibody cocktail targeting Marburg virus, with phases including production, efficacy testing in animal models, pharmacokinetics/pharmacodynamics evaluation, and manufacturing cell line development. The project aims to set the stage for further development and potential FDA approval under the Animal Rule.